Evidence map›Paper›PMID 34206674›Full record

ArticlePolymers2021

In Vitro Interaction of Doxorubicin-Loaded Silk Sericin Nanocarriers with MCF-7 Breast Cancer Cells Leads to DNA Damage.

Ionuț-Cristian Radu, Cătălin Zaharia, Ariana Hudiță, Eugenia Tanasă, Octav Ginghină, Minodora Marin, Bianca Gălățeanu, Marieta Costache

Abstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Development of New Collagen/Clay Composite Biomaterials.International journal of molecular sciences · 2021
    Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ionuț-Cristian RaduAdvanced Polymer Materials Group, Faculty of Applied Chemistry and Materials Science, University Politehnicaof Bucharest, 1-7 Gh. Polizu Street, Sector 1, 011061 Bucharest, Romania.
Cătălin ZahariaAdvanced Polymer Materials Group, Faculty of Applied Chemistry and Materials Science, University Politehnicaof Bucharest, 1-7 Gh. Polizu Street, Sector 1, 011061 Bucharest, Romania.ORCID 0000-0002-7522-467X
Ariana HudițăDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0002-9439-9432
Eugenia TanasăUniversity Politehnica of Bucharest, 313 Splaiul Independentei, Sector 6, 060042 Bucharest, Romania.
Octav GinghinăDepartment of Surgery, "Sf. Ioan" Clinical Emergency Hospital, 042122 Bucharest, Romania.
Minodora MarinAdvanced Polymer Materials Group, Faculty of Applied Chemistry and Materials Science, University Politehnicaof Bucharest, 1-7 Gh. Polizu Street, Sector 1, 011061 Bucharest, Romania.
Bianca GălățeanuDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0001-8093-1750
Marieta CostacheDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0002-8103-3693

Funding

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P4-ID-PCE-2020-1448, within PNCDI III
6 · The paper itself

Abstract

In this paper,

Indexed as

breast cancerdoxorubicinnanoprecipitationsilk sericin

Identifiers

PMID34206674
PMCPMC8271558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.